메뉴 건너뛰기




Volumn 75, Issue 4, 1996, Pages 298-303

Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation

Author keywords

Diphtheria tetanus pertussis vaccine; Haemophilus; Immunisation; Influenzae type b vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

EID: 0029951225     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.4.298     Document Type: Article
Times cited : (24)

References (32)
  • 1
    • 0029671047 scopus 로고    scopus 로고
    • Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme
    • Hargreaves RM, Slack MPE, Howard AJ, Anderson E, Ramsay ME. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996;312:160-1.
    • (1996) BMJ , vol.312 , pp. 160-161
    • Hargreaves, R.M.1    Slack, M.P.E.2    Howard, A.J.3    Anderson, E.4    Ramsay, M.E.5
  • 2
    • 0025996477 scopus 로고
    • Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants
    • Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991;10:758-63.
    • (1991) Pediatr Infect Dis J , vol.10 , pp. 758-763
    • Watemberg, N.1    Dagan, R.2    Arbelli, Y.3
  • 3
    • 0027204111 scopus 로고
    • Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphrheria-tetanus-pertussis vaccine at two, four and six months of age
    • Avendano A, Ferreccio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphrheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993;12:638-43.
    • (1993) Pediatr Infect Dis J , vol.12 , pp. 638-643
    • Avendano, A.1    Ferreccio, C.2    Lagos, R.3
  • 4
    • 0027955668 scopus 로고
    • Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants
    • Kaplan SL, Lauer BA, Ward MA, et al. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994;124:323-7.
    • (1994) J Pediatr , vol.124 , pp. 323-327
    • Kaplan, S.L.1    Lauer, B.A.2    Ward, M.A.3
  • 5
    • 0028917162 scopus 로고
    • Safety and immunogenicity of PRP-T combined with DTP: Excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period
    • Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995;95:522-7.
    • (1995) Pediatrics , vol.95 , pp. 522-527
    • Miller, M.A.1    Meschievitz, C.K.2    Ballanco, G.A.3    Daum, R.S.4
  • 6
    • 0025937312 scopus 로고
    • The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids pertussis vaccine at two, four and six months of age
    • Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991;10:764-71.
    • (1991) Pediatr Infect Dis J , vol.10 , pp. 764-771
    • Ferreccio, C.1    Clemens, J.2    Avendano, A.3
  • 7
    • 0028197455 scopus 로고
    • Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine
    • Dagan R, Botujansky C, Watemberg N, et al. Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J 1994;13:356-62.
    • (1994) Pediatr Infect Dis J , vol.13 , pp. 356-362
    • Dagan, R.1    Botujansky, C.2    Watemberg, N.3
  • 8
    • 0026565807 scopus 로고
    • Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine
    • Clemens JD, Ferreccio C, Levine MM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992; 267:673-8.
    • (1992) JAMA , vol.267 , pp. 673-678
    • Clemens, J.D.1    Ferreccio, C.2    Levine, M.M.3
  • 9
    • 0028266060 scopus 로고
    • Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age
    • Gold R, Scheifele D, Barreto L, et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994;13:348-55.
    • (1994) Pediatr Infect Dis J , vol.13 , pp. 348-355
    • Gold, R.1    Scheifele, D.2    Barreto, L.3
  • 10
    • 0027369929 scopus 로고
    • Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid pertussis vaccine-tetanus toxoid?
    • Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid pertussis vaccine-tetanus toxoid? Can Med Assoc J 1995;149: 1105-12.
    • (1995) Can Med Assoc J , vol.149 , pp. 1105-1112
    • Scheifele, D.1    Barreto, L.2    Meekison, W.3    Guasparini, R.4    Friesen, B.5
  • 11
    • 0026512243 scopus 로고
    • Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age
    • Booy R, Aitken SJ, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 1992;339:507-10.
    • (1992) Lancet , vol.339 , pp. 507-510
    • Booy, R.1    Aitken, S.J.2    Taylor, S.3
  • 12
    • 0027181326 scopus 로고
    • Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine
    • Ramsay ME, Rao M, Begg NT, Redhead K, Attwell AM. Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine. Lancet 1993;342:203-5.
    • (1993) Lancet , vol.342 , pp. 203-205
    • Ramsay, M.E.1    Rao, M.2    Begg, N.T.3    Redhead, K.4    Attwell, A.M.5
  • 13
    • 0015810637 scopus 로고
    • Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies
    • Robbins JB, Parke JC, Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
    • (1973) Pediatr Res , vol.7 , pp. 103-110
    • Robbins, J.B.1    Parke, J.C.2    Schneerson, R.3    Whisnant, J.K.4
  • 14
    • 0008834204 scopus 로고
    • The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
    • Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
    • (1983) J Infect Dis , vol.147 , pp. 1100
    • Kayhty, H.1    Peltola, H.2    Karanko, V.3    Makela, P.H.4
  • 15
    • 0021254144 scopus 로고
    • Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine
    • Peltola H, Kayhty H, Virtanen M, Makela PH. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med 1984;310:1561-6.
    • (1984) N Engl J Med , vol.310 , pp. 1561-1566
    • Peltola, H.1    Kayhty, H.2    Virtanen, M.3    Makela, P.H.4
  • 16
    • 0021448815 scopus 로고
    • The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
    • Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
    • (1984) J Infect Dis , vol.149 , pp. 1034-1035
    • Anderson, P.1
  • 17
    • 0001422530 scopus 로고
    • Circulating antitoxin at the onset of diphtheria in 425 patients
    • Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients. J Immunol 1946;54:325-47.
    • (1946) J Immunol , vol.54 , pp. 325-347
    • Ipsen, J.1
  • 18
    • 0001188911 scopus 로고
    • The prophylactic dose of homologous tetanus antitoxin
    • McComb JA. The prophylactic dose of homologous tetanus antitoxin. N Engl J Med 1964;270:175-8.
    • (1964) N Engl J Med , vol.270 , pp. 175-178
    • McComb, J.A.1
  • 19
    • 0014513924 scopus 로고
    • Diphtheria and tetanus toxoids
    • Smith JW. Diphtheria and tetanus toxoids. Br Med Bull 1969;25:177-82.
    • (1969) Br Med Bull , vol.25 , pp. 177-182
    • Smith, J.W.1
  • 20
    • 0026596451 scopus 로고
    • Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule
    • Booy R, Taylor SA, Dobson SR, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475-8.
    • (1992) Arch Dis Child , vol.67 , pp. 475-478
    • Booy, R.1    Taylor, S.A.2    Dobson, S.R.3
  • 22
    • 0028879984 scopus 로고
    • Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection
    • Begg NT, Miller E, Fairley CK, et al. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine 1995;13:1547-50.
    • (1995) Vaccine , vol.13 , pp. 1547-1550
    • Begg, N.T.1    Miller, E.2    Fairley, C.K.3
  • 25
    • 84948725401 scopus 로고
    • FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children
    • Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children. JAMA 1993; 269:2359.
    • (1993) JAMA , vol.269 , pp. 2359
  • 26
    • 0010619389 scopus 로고    scopus 로고
    • Combined Hib/DTP vaccines
    • Department of Health. Combined Hib/DTP vaccines. CMO's Update 1996;10:1.
    • (1996) CMO's Update , vol.10 , pp. 1
  • 27
    • 0026645375 scopus 로고
    • Symptoms after accelerated immunisation
    • Ramsay ME, Rao M, Begg NT. Symptoms after accelerated immunisation. BMJ 1992;304:1534-6.
    • (1992) BMJ , vol.304 , pp. 1534-1536
    • Ramsay, M.E.1    Rao, M.2    Begg, N.T.3
  • 28
    • 0024357076 scopus 로고
    • Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain
    • Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy SM. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J 1989;8:502-7.
    • (1989) Pediatr Infect Dis J , vol.8 , pp. 502-507
    • Baraff, L.J.1    Manclark, C.R.2    Cherry, J.D.3    Christenson, P.4    Marcy, S.M.5
  • 29
    • 0026775396 scopus 로고
    • Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine
    • Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J Pediatr 1992;121:355-62.
    • (1992) J Pediatr , vol.121 , pp. 355-362
    • Fritzell, B.1    Plotkin, S.2
  • 30
    • 0026052745 scopus 로고
    • Differences in antibody response to whole-cell pertussis vaccines
    • Edwards KM, Decker MD, Halsey NA, et al. Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 1991;88:1019-23.
    • (1991) Pediatrics , vol.88 , pp. 1019-1023
    • Edwards, K.M.1    Decker, M.D.2    Halsey, N.A.3
  • 31
    • 0026760236 scopus 로고
    • Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines
    • Baker JD, Halperin SA, Edwards K, Miller B, Decker M, Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr 1992;121:523-7.
    • (1992) J Pediatr , vol.121 , pp. 523-527
    • Baker, J.D.1    Halperin, S.A.2    Edwards, K.3    Miller, B.4    Decker, M.5    Stephens, D.6
  • 32
    • 0028156017 scopus 로고
    • Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine
    • Barington T, Gyhrs A, Kristensen K, Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994;62: 9-14.
    • (1994) Infect Immun , vol.62 , pp. 9-14
    • Barington, T.1    Gyhrs, A.2    Kristensen, K.3    Heilmann, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.